Fiera Capital Corp Ligand Pharmaceuticals Inc Transaction History

Fiera Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $910,713 - $1.27 Million	-10,559 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $56,159 - $67,644	-523 Reduced 4.72%	10,559 $1.21 Million
Q1 2019 May 10, 2019	SELL	$105.93 - $142.47 $500,519 - $673,170	-4,725 Reduced 29.89%	11,082 $1.39 Million
Q4 2018 Feb 12, 2019	BUY	$128.36 - $272.13 $2.03 Million - $4.3 Million	15,807 New	15,807 $2.15 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.